Early research (Phase 1)Study completedNCT00055705What this trial is testingPV701 in Treating Patients With Advanced or Recurrent Peritoneal CancerWho this might be right forCancer Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Study completedNCT00101972What this trial is testingRAV12 in Treating Patients With Metastatic or Recurrent AdenocarcinomaWho this might be right forCancer MacroGenics 53
Early research (Phase 1)Study completedNCT00031681What this trial is testing7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)Who this might be right forAdvanced Adult Primary Liver CancerCarcinoma of the AppendixEstrogen Receptor-negative Breast Cancer+85 more National Cancer Institute (NCI) 41
Not applicableStudy completedNCT01344837What this trial is testingBiomarkers in Blood and Tissue Samples From Patients With Uterine CancerWho this might be right forEndometrial Serous AdenocarcinomaStage I Uterine Corpus CancerStage II Uterine Corpus Cancer+2 more Gynecologic Oncology Group 360
Early research (Phase 1)WithdrawnNCT04498520What this trial is testingAbexinostat, Palbociclib, and Fulvestrant for the Treatment of Breast or Gynecologic CancerWho this might be right forAnatomic Stage III Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8Anatomic Stage IIIB Breast Cancer AJCC v8+32 more Pamela Munster
Not applicableLooking for participantsNCT06349642What this trial is testingImmune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic PlatformWho this might be right forEarly Stage Triple-Negative Breast CarcinomaMetastatic Bladder Urothelial CarcinomaMetastatic Cervical Carcinoma+24 more Mayo Clinic 324
Early research (Phase 1)Study completedNCT00003439What this trial is testingInterleukin-12 in Treating Patients With Refractory Advanced-Stage Ovarian Cancer or Abdominal CancerWho this might be right forCancer National Cancer Institute (NCI) 36
Testing effectiveness (Phase 2)Study completedNCT00870337What this trial is testingEverolimus in Treating Patients With Relapsed or Metastatic Endometrial CancerWho this might be right forEndometrial Cancer ARCAGY/ GINECO GROUP 44
Not applicableStudy completedNCT04670445What this trial is testingImproving Patient and Caregiver Understanding of Risks and Benefits of Immunotherapy for Advanced CancerWho this might be right forStage IV MelanomaAdvanced Lung CancerStage IV Non-Small Cell Lung Cancer+19 more Massachusetts General Hospital 199
Early research (Phase 1)Study completedNCT00448643What this trial is testingWhole-Abdominal Radiation Therapy and Cisplatin in Treating Patients With Stage III or Stage IV Endometrial Cancer That Has Been Removed by SurgeryWho this might be right forEndometrial Cancer University of Miami 12
Testing effectiveness (Phase 2)Study completedNCT00770185What this trial is testingRidaforolimus in Treating Patients With Recurrent Metastatic and/or Locally Advanced Endometrial CancerWho this might be right forEndometrial Cancer NCIC Clinical Trials Group 35
Testing effectiveness (Phase 2)Study completedNCT01935934What this trial is testingCabozantinib S-Malate in Treating Patients With Recurrent or Metastatic Endometrial CancerWho this might be right forEndometrial Adenosquamous CarcinomaEndometrial Clear Cell AdenocarcinomaEndometrial Mixed Cell Adenocarcinoma+7 more National Cancer Institute (NCI) 102
Testing effectiveness (Phase 2)Ended earlyNCT02112552What this trial is testingPaclitaxel and Intraperitoneal Carboplatin Followed by Radiation Therapy in Treating Patients With Stage IIIC-IV Uterine CancerWho this might be right forEndometrial Serous AdenocarcinomaStage IIIA Uterine Corpus CancerStage IIIB Uterine Corpus Cancer+4 more Albert Einstein College of Medicine 4